Moderna Inc
NASDAQ:MRNA
Moderna Inc
NASDAQ:MRNA
Price:
52.56
USD
-1.55%
Market Closed
Market Cap:
$20.8B
Balance Sheet
Balance Sheet Decomposition
Moderna Inc
Moderna Inc
Balance Sheet Decomposition is not available for
Moderna Inc
Moderna Inc
Balance Sheet
Moderna Inc
Moderna Inc
Currency: USD
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
50
|
135
|
658
|
236
|
2 624
|
6 848
|
3 205
|
2 907
|
1 927
|
2 595
|
|
| Cash Equivalents |
50
|
135
|
658
|
236
|
2 624
|
6 848
|
3 205
|
2 907
|
1 927
|
2 595
|
|
| Short-Term Investments |
1 008
|
621
|
863
|
867
|
1 984
|
3 879
|
6 697
|
5 697
|
5 098
|
3 204
|
|
| Total Receivables |
18
|
17
|
31
|
16
|
1 411
|
3 296
|
1 664
|
1 081
|
592
|
284
|
|
| Accounts Receivables |
14
|
13
|
13
|
5
|
1 391
|
3 175
|
1 385
|
892
|
358
|
184
|
|
| Other Receivables |
4
|
4
|
18
|
11
|
20
|
121
|
279
|
189
|
234
|
100
|
|
| Inventory |
0
|
0
|
0
|
0
|
47
|
1 441
|
949
|
202
|
117
|
153
|
|
| Other Current Assets |
11
|
11
|
11
|
9
|
233
|
607
|
916
|
438
|
365
|
308
|
|
| Total Current Assets |
1 087
|
783
|
1 563
|
1 129
|
6 298
|
16 071
|
13 431
|
10 325
|
8 099
|
6 544
|
|
| PP&E Net |
81
|
139
|
212
|
288
|
387
|
1 383
|
2 139
|
2 658
|
2 955
|
2 853
|
|
| PP&E Gross |
81
|
139
|
212
|
288
|
387
|
1 383
|
2 139
|
2 658
|
2 955
|
2 853
|
|
| Accumulated Depreciation |
28
|
48
|
64
|
95
|
120
|
352
|
658
|
433
|
527
|
737
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
44
|
40
|
45
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
52
|
52
|
52
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
97
|
161
|
|
| Long-Term Investments |
237
|
146
|
173
|
160
|
639
|
6 843
|
8 318
|
4 743
|
2 508
|
2 342
|
|
| Other Long-Term Assets |
12
|
16
|
14
|
13
|
13
|
372
|
1 970
|
604
|
391
|
341
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
52
|
52
|
52
|
|
| Total Assets |
1 417
N/A
|
1 084
-24%
|
1 962
+81%
|
1 589
-19%
|
7 337
+362%
|
24 669
+236%
|
25 858
+5%
|
18 426
-29%
|
14 142
-23%
|
12 338
-13%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
28
|
21
|
31
|
7
|
18
|
302
|
487
|
520
|
405
|
317
|
|
| Accrued Liabilities |
25
|
73
|
79
|
71
|
476
|
1 518
|
2 136
|
1 823
|
1 441
|
1 403
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
24
|
165
|
161
|
0
|
23
|
25
|
|
| Other Current Liabilities |
110
|
98
|
113
|
65
|
3 871
|
7 143
|
2 139
|
672
|
337
|
242
|
|
| Total Current Liabilities |
163
|
191
|
223
|
143
|
4 389
|
9 128
|
4 923
|
3 015
|
2 206
|
1 987
|
|
| Long-Term Debt |
13
|
16
|
33
|
39
|
110
|
599
|
912
|
575
|
39
|
610
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
231
|
249
|
|
| Other Liabilities |
400
|
252
|
176
|
233
|
277
|
797
|
900
|
982
|
765
|
842
|
|
| Total Liabilities |
575
N/A
|
459
-20%
|
432
-6%
|
415
-4%
|
4 775
+1 051%
|
10 524
+120%
|
6 735
-36%
|
4 572
-32%
|
3 241
-29%
|
3 688
+14%
|
|
| Equity | |||||||||||
| Common Stock |
1 177
|
1 177
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
366
|
622
|
1 007
|
1 496
|
2 244
|
9 958
|
18 320
|
13 606
|
10 045
|
7 223
|
|
| Additional Paid In Capital |
31
|
72
|
2 538
|
2 669
|
4 802
|
4 211
|
1 173
|
371
|
866
|
1 382
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
1
|
2
|
3
|
0
|
362
|
114
|
10
|
38
|
|
| Other Equity |
0
|
1
|
0
|
0
|
0
|
24
|
8
|
9
|
20
|
7
|
|
| Total Equity |
842
N/A
|
625
-26%
|
1 530
+145%
|
1 175
-23%
|
2 561
+118%
|
14 145
+452%
|
19 123
+35%
|
13 854
-28%
|
10 901
-21%
|
8 650
-21%
|
|
| Total Liabilities & Equity |
1 417
N/A
|
1 084
-24%
|
1 962
+81%
|
1 589
-19%
|
7 337
+362%
|
24 669
+236%
|
25 858
+5%
|
18 426
-29%
|
14 142
-23%
|
12 338
-13%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
324
|
324
|
329
|
337
|
399
|
403
|
385
|
382
|
386
|
394
|
|
Switch to:
Switch to:
See Also
Discover More
